Suntrust Banks’s Exelixis EXEL Stock Holding History

Suntrust Banks’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-187,812	Closed	-$664K	–	1488
2014 Q1	$664K	Sell	187,812 -84,927	-31%	-$578K	﹤0.01%	1173
2013 Q4	$1.67M	Sell	272,739 -1,652	-0.6%	-$9.1K	0.01%	735
2013 Q3	$1.6M	Sell	274,391 -4,955	-2%	-$25.6K	0.01%	715
2013 Q2	$1.27M	Buy	+279,346	New	+$1.32M	0.01%	756

Other funds holding EXEL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Suntrust Banks's EXEL Position: Q2 2014 in Review

Suntrust Banks sold out of Exelixis (EXEL) in Q2 2014, closing a stake of 187,812 shares — an estimated $664K sold.

Suntrust Banks first reported a position in EXEL in Q2 2013 and held it in 4 quarters. The position peaked at $1.67M in Q4 2013. 136 funds tracked by Wall St. Rank hold EXEL as of Q2 2014.

Suntrust Banks reported no remaining Exelixis position as of Q2 2014 after selling out during the quarter.
Suntrust Banks sold 187,812 Exelixis shares in Q2 2014, an estimated $664K.
Suntrust Banks first reported a position in Exelixis in Q2 2013 and held it in 4 quarters.
Suntrust Banks's Exelixis position peaked at $1.67M in Q4 2013.
136 funds tracked by Wall St. Rank held Exelixis as of Q2 2014.

Based on Suntrust Banks's 13F filing for Q2 2014, filed 14 Aug 2014.